Walleye Capital’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.6K Sell
7,500
-38,300
-84% -$418K ﹤0.01% 4015
2026
Q1
$531K Sell
45,800
-25,400
-36% -$317K ﹤0.01% 2619
2025
Q4
$814K Buy
71,200
+37,700
+113% +$443K ﹤0.01% 2603
2025
Q3
$425K Sell
33,500
-52,500
-61% -$762K ﹤0.01% 2745
2025
Q2
$1.37M Sell
86,000
-45,600
-35% -$682K 0.01% 1811
2025
Q1
$1.97M Buy
131,600
+11,800
+10% +$209K 0.01% 1426
2024
Q4
$2.27M Buy
119,800
+18,800
+19% +$398K 0.01% 1669
2024
Q3
$2.73M Buy
101,000
+82,600
+449% +$2.11M 0.01% 1665
2024
Q2
$458K Sell
18,400
-15,400
-46% -$442K ﹤0.01% 3581
2024
Q1
$1.12M Buy
+33,800
New +$1.15M ﹤0.01% 2482
2020
Q1
Sell
-10,500
Closed -$594K 1764
2019
Q4
$594K Sell
10,500
-66,500
-86% -$3.71M 0.04% 601
2019
Q3
$4.11M Buy
77,000
+14,700
+24% +$790K 0.24% 74
2019
Q2
$3.64M Buy
62,300
+56,300
+938% +$3.03M 0.4% 24
2019
Q1
$298K Buy
+6,000
New +$264K 0.05% 606

Other funds holding XRAY

Walleye Capital's XRAY Position: Q2 2026 in Review

Walleye Capital reduced its Dentsply Sirona (XRAY) stake by 9.3% in Q2 2026, selling an estimated $15K and leaving 13,429 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #3695.

Walleye Capital first reported a position in XRAY in Q1 2019 and has held it in 18 quarters since. The position peaked at $8.2M in Q4 2024. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Walleye Capital held 13,429 shares of Dentsply Sirona worth $142K as of Q2 2026.
  • Walleye Capital sold 1,378 Dentsply Sirona shares in Q2 2026, an estimated $15K.
  • Dentsply Sirona made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3695 holding.
  • Walleye Capital first reported a position in Dentsply Sirona in Q1 2019 and has held it in 18 quarters since.
  • Walleye Capital's Dentsply Sirona position peaked at $8.2M in Q4 2024.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.